Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-24 @ 3:03 PM
NCT ID:
NCT04801459
Eligibility Criteria:
Inclusion Criteria:
* 1\) Pathological examination confirmation the adenocarcinoma of stomach before surgery
* 2\) Physical conditions compliance with the requirements for curative gastrectomy
* 3\) Consent to undergo the D2 lymphadenectomy, and the dissected proportion of stomach no less than 2/3
* 4\) Comply with the protocol during the whole study period
* 5\) No neoadjuvant therapy administration
* 6\) Sign informed consent and permission of withdraw in the whole study period
* 7\) Consent to provide the tissue specimens after surgery for this study
* 8\) Estimation the overall survival after surgery no less than 6 months
* 9\) No anesthesia or operation contraindication disease
* 10\) cT1-4N0-2M0 stage demonstration by CT and endoscopic ultrasonography examinations
* 11\) Negative cytological detection in operation
* 12\) No seriously concomitance's diseases
* 13\) Karnofsky Performance Scores (KPS) more than 60
* 14\) Examined lymph node count no less than 16
Exclusion Criteria:
* 1\) Women during pregnant stage and breast-feed stage
* 2\) Women of childbearing age without any contraceptive measures
* 3\) Severe congestive heart failure, frequent arrhythmia, or myocardial infarction within 12 months
* 4\) Immunosuppressive therapists for organ transplantation
* 5\) Seriously uncontrolled recurrent infection
* 6\) other malignant tumors
* 7\) No abilities of self-knowledge or mental disorders
* 8\) Participating in other clinical trials
* 9\) Siewert I and II esophagogastric junction tumors
* 10\) Serious internal diseases obstruction surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04801459
Study Brief:
Protocol Section:
NCT04801459